Manual Acupuncture (MA) for Asymptomatic Hyperuricemia (HUA)

NCT06824376 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2025-03-30

No results posted yet for this study

Summary

Assess the effectiveness of manual acupuncture in modulating serum uric acid levels among patients diagnosed with asymptomatic hyperuricemia.

Conditions

  • Asymptomatic Hyperuricemia

Interventions

DEVICE

Manual acupuncture

After sterilisation, the sharp needles will be inserted into the deep tissue layers of acupoints. Acupuncturists will tried to elicit acupuncture de-qi sensation by the manual manipulation of needles. Within a 30-minute period, manual manipulation for each acupoint will last at least 10 seconds and wil repeated four times with intervals of 10-minute.

DEVICE

Sham acupuncture

After sterilisation, Streitberger placebo needles with blunt tip will be used. It can be fixed on the surface of the sham points without piercing the skin. Within a 30-minute period, each point will undergo a simulated twisting motion of the needle for at least 10 seconds, and this will be repeated four times at 10-minute intervals.

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Xianning Hospital of Traditional Chinese Medicine, China

    collaborator UNKNOWN
  • Beijing Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Qianjiang Central Hospital, China

    collaborator UNKNOWN
  • Hainan General Hospital

    collaborator OTHER
  • Yichang Central People's Hospital

    collaborator OTHER
  • Wuhan No.1 Hospital

    collaborator OTHER
  • The Second Hospital of Huangshi

    collaborator UNKNOWN
  • Puyang Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Shenghao Tu

    lead OTHER

Principal Investigators

  • Shenghao Tu, Ph.D · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-25
Primary Completion
2026-10-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06824376 on ClinicalTrials.gov